Clareo Health | Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Teva Takeda Pharma Ltd.
The drug being tested in this study is called Glatiramer acetate is being tested to treat people who have Multiple sclerosis. This study will look at the safety and efficacy of Glatiramer acetate in patients with multiple sclerosis in the routine clinical setting.
The study will enroll approximately 1000 patients.
• Glatiramer acetate subcutaneous injection syringe
This multi-center trial will be conducted in Japan.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- All patients treated with Copaxone from the first day of market launch of the product
